Intellia`s In Vivo CRISPR Therapy First To Succeed In Phase 3
28 Apr 2026 //
ENDPOINTS
J&J Sees AI Halving The Time To Generate Drug Development Leads
28 Apr 2026 //
REUTERS
Umang Vohra appointed Group CEO of Cohance Lifesciences
28 Apr 2026 //
INDPHARMAPOST
Abbvie Seeks FDA Approval For SKYRIZI Subcutaneous Induction
28 Apr 2026 //
PRESS RELEASE
EC Approves Crinetics` PALSONIFY for Acromegaly in Adults
28 Apr 2026 //
GLOBENEWSWIRE
FDA Proposes to withdraw Amgen`s drug for Rare Autoimmune Disease
28 Apr 2026 //
REUTERS
Eli to buy Ajax Pharma for up to $2.3 billion in blood cancer
28 Apr 2026 //
REUTERS
Ligand Pharma to Acquire Biotech Royalty Rights Buyer XOMA
28 Apr 2026 //
REUTERS
Johnson & Johnson to offer four prescription medicines on TrumpRx
27 Apr 2026 //
REUTERS
Drugs In Development
Market Intel

Market Place
Sourcing Support